Significance of intermediary reduction products in the histochemical demonstration of dehydrogenase activity.
D000232:Adenofibroma / Q000201:enzymology* / Q000473:pathology; D001391:Azo Compounds / Q000378:metabolism*; D001706:Biopsy; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology; D002277:Carcinoma / Q000201:enzymology* / Q000473:pathology; D002278:Carcinoma in Situ / Q000201:enzymology* / Q000473:pathology; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism*; D010088:Oxidoreductases / Q000378:metabolism*
D001391:Azo Compounds; D010088:Oxidoreductases; D009247:NADH, NADPH Oxidoreductases